Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Detoxification in hemosiderosis.

P Simon

    Blood Purification
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Transfusional iron overload in chronic renal failure patients requires management through oral iron therapy and optimized transfusions. Desferrioxamine chelation therapy can treat iron overload and potential aluminum co-overload in dialysis patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Surgery of thoracic and thoraco-abdominal aneurysms using deep hypothermia and cardiovascular arrest with continuous administration of blood cardioplegia].

    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·1995
    Same author

    Echocardiographic results after repair of incompetent bicuspid aortic valves.

    The Annals of thoracic surgery·1995
    Same author

    [Which surgery for which breast cancer?].

    Revue medicale de Bruxelles·1995
    Same author

    Aortic valve resuspension in ascending aortic aneurysm repair with aortic insufficiency.

    The Annals of thoracic surgery·1995
    Same author

    The Breuer-Hering reflex in humans. Effects of pulmonary denervation and hypocapnia.

    American journal of respiratory and critical care medicine·1995
    Same author

    [Annual incidence of IgA nephropathy (Berger syndrome) in France].

    Presse medicale (Paris, France : 1983)·1995
    Same journal

    Could serum CA125 aid the clinical assessment of volume status of end-stage kidney disease patients treated by peritoneal dialysis patients?

    Blood purification·2026
    Same journal

    From Bench to Bedside: Implications and Interventions for Endotoxin Exposure in Lipopolysaccharide-Induced Apoptosis and Eryptosis.

    Blood purification·2026
    Same journal

    Feasibility Study of a Smartphone App and Web Portal for Remote Monitoring of Chronic Kidney Disease and Peritoneal Dialysis populations: A mixed-method study.

    Blood purification·2026
    Same journal

    Treatment of Focal Segmental Glomerulosclerosis in Low- and Middle-Income Countries: Emerging Extracorporeal Therapies.

    Blood purification·2026
    Same journal

    Creatinine Paradox in CRRT: Higher Levels, Lower Mortality - A MIMIC-IV Validation Study.

    Blood purification·2026
    Same journal

    Expanded Home Hemodialysis trial (HHDx): Study Design and Baseline Characteristics of a Pragmatic Real-World Cohort.

    Blood purification·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Hematology
    • Pharmacology

    Background:

    • Transfusional iron overload is a significant complication in patients with chronic renal failure, particularly those on dialysis.
    • Iron absorption control mechanisms remain functional in dialysis patients, supporting oral iron therapy.
    • Anemia management in dialysis patients can lead to iron overload due to frequent transfusions.

    Purpose of the Study:

    • To review the therapeutic approaches for managing transfusional iron overload in chronic renal failure.
    • To discuss the efficacy of oral iron therapy, erythrocyte selection, and chelation therapy.
    • To explore the potential for iron and aluminum co-overload and its management.

    Main Methods:

    • Review of existing literature on iron overload in chronic renal failure.

    Related Experiment Videos

  • Analysis of therapeutic strategies including oral iron, transfusion practices, and chelation therapy.
  • Examination of studies investigating iron and aluminum overload and desferrioxamine treatment.

    • Main Results:

    • Oral iron therapy is recommended for most dialysis patients due to intact iron absorption control.
    • Using younger erythrocytes for transfusions can help reduce iron overload.
    • Desferrioxamine effectively removes iron and can also chelate aluminum, addressing potential co-overload.

    Conclusions:

    • Effective management of transfusional iron overload in chronic renal failure involves prevention and treatment strategies.
    • Oral iron and optimized transfusion practices are key preventive measures.
    • Desferrioxamine offers a therapeutic option for established iron overload and concurrent aluminum toxicity.